Abstract

For some time, glycopeptide antibiotics have been considered the last line of defense against Methicillin-resistant Staphylococcus aureus (MRSA). However, vancomycin resistance of Gram-positive bacteria is an increasingly emerging worldwide health problem. The mode of action of glycopeptide antibiotics is essentially the binding of peptidoglycan cell-wall fragments terminating in the d-Ala-d-Ala sequence to the carboxylate anion binding pocket of the antibiotic. Dimerization of these antibiotics in aqueous solution was shown to persist and even to enhance the antibacterial effect in a co-operative manner. Some works based on solid state (ss) Nuclear Magnetic Resonance (NMR) studies questioned the presence of dimers under the conditions of ssNMR while in a few cases, higher-order oligomers associated with contiguous back-to-back and face-to-face dimers were observed in the crystal phase. However, it is not proved if such oligomers persist in aqueous solutions. With the aid of 15N-labelled eremomycin using 15N relaxation and diffusion NMR methods, we observed tetramers and octamers when the N-Ac-d-Ala-d-Ala dipeptide was added. To the contrary, the N-Ac-d-Ala or (N-Ac)2-l-Lys-d-Ala-d-Ala tripeptide did not induce higher-order oligomers. These observations are interesting examples of tailored supramolecular self-organization. New antimicrobial tests have also been carried out with these self-assemblies against MRSA and VRE (resistant) strains.

Highlights

  • If the fear that infections by both Methicillin-resistant Staphylococcus aureus (MRSA)and vancomycin-resistant enterococci (VRE) bacteria will spread and cause worldwide epidemics becomes true, we may return to the pre-penicillin age in which bacterial infection contributed significantly to morbidity rates

  • Using an 15 N-labelled glycopeptide antibiotic for the first time [27], we proved the dynamic equivalence of the two sides of the dimeric eremomycin and the flexibility of the residue-3 Asn sidechain

  • We explore the higher-order oligomeric states of eremomycin in aqueous solution using 15 N-labelled and unlabelled forms bound to different cell wall analogue peptides

Read more

Summary

Introduction

If the fear that infections by both Methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin-resistant enterococci (VRE) bacteria will spread and cause worldwide epidemics becomes true, we may return to the pre-penicillin age in which bacterial infection contributed significantly to morbidity rates. Vancomycin-resistant bacteria have adopted a simple, but powerful device for their survival: the essential D-Ala-D-Ala target sequence normally found in vancomycin-sensitive bacteria has changed to D-Ala-D-Lac. Experimental and theoretical studies have shown that vancomycin binds less strongly to such targets [1]. The newer VanC type resistance arises from the sixfold-lower affinity of vancomycin for acyl-D-Ala-D-Ser than for acyl-D-Ala-D-Ala [2]. An in-depth review of the structural biology of molecular recognition by vancomycin antibiotics was published [5]. It is known that most vancomycin antibiotics exert an enhanced

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call